ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
143 hedge funds and large institutions have $699M invested in iTeos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
-9
Holders Change %
-5.92%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
63
Reduced
34
Closed
28
Calls
$201K
Puts
–
Net Calls
+$201K
Net Calls Change
-$3.97M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$25.2M |
| 2 |
BlackRock
New York
|
$82.2M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$8.88M |
| 4 |
Millennium Management
New York
|
$14.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$5.68M |
